ROCKET PHARMACEUTICALS INC

Q1 2025 13F holders

CUSIP
77313F114
Type
Equity
Class
*W EXP 09/02/202
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type